The study unveils a unique mechanism by which SIRT7 promotes proliferation of non-small-cell lung cancer that may be exploited to increase cellular levels of ARF for antitumor therapies in cancers with intact ARF expression. The gene discussed is CDKN2A; the disease is cancer.